Related references
Note: Only part of the references are listed.Mutations in the SPTLC2 Subunit of Serine Palmitoyltransferase Cause Hereditary Sensory and Autonomic Neuropathy Type I
Annelies Rotthier et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
A Disease-causing Mutation in the Active Site of Serine Palmitoyltransferase Causes Catalytic Promiscuity
Kenneth Gable et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids
Anke Penno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Deoxysphingoid bases as plasma markers in Diabetes mellitus
Mariana Bertea et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation
Annelies Rotthier et al.
BRAIN (2009)
Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS
Nicholas C. Zitomer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Overexpression of the Wild-Type SPT1 Subunit Lowers Desoxysphingolipid Levels and Rescues the Phenotype of HSAN1
Florian S. Eichler et al.
JOURNAL OF NEUROSCIENCE (2009)
A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated
Thorsten Hornemann et al.
NEUROGENETICS (2009)
Roles of L-serine and sphingolipid synthesis in brain development and neuronal survival
Yoshio Hirabayashi et al.
PROGRESS IN LIPID RESEARCH (2008)
Diabetic neuropathy - a review
Gerard Said
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway
M. Salcedo et al.
APOPTOSIS (2007)
Late-onset hereditary sensory neuropathy type I due to SPTLC1 mutation:: Autopsy findings
Andrea J. Lindahl et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2006)
Treatment with amino acids in serine deficiency disorders
TJ de Koning
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I)
H Houlden et al.
BRAIN (2006)
Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2005)
Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice
MR Hojjati et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Novel class of glycosphingolipids involved in male fertility
R Sandhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells
VN Dedov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism
K Hanada
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
L-serine in disease and development
TJ De Koning et al.
BIOCHEMICAL JOURNAL (2003)
Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase
K Gable et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SPTLC1 is mutated in hereditary sensory neuropathy, type 1
K Bejaoui et al.
NATURE GENETICS (2001)
Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I
JL Dawkins et al.
NATURE GENETICS (2001)
The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers
R Cuadros et al.
CANCER LETTERS (2000)
Share Paper
